×
About 76,242 results

ALLMedicine™ Chronic Obstructive Pulmonary Disease Center

Research & Reviews  36,101 results

Use of antidiabetic medications and risk of chronic obstructive pulmonary disease exace...
https://doi.org/10.1186/s12931-020-01547-1
Respiratory Research; Wang MT, Lai JH et. al.

Dec 3rd, 2020 - Exacerbation of chronic obstructive pulmonary disease (COPD) severely impacts the quality of life and causes high mortality and morbidity. COPD is involved with systemic and pulmonary inflammation, which may be attenuated with antidiabetic agents ...

Characteristics Associated with Accelerated Lung Function Decline in a Primary Care Pop...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701160
International Journal of Chronic Obstructive Pulmonary Disease; Whittaker HR, Pimenta JM et. al.

Dec 3rd, 2020 - Estimates for lung function decline in chronic obstructive pulmonary disease (COPD) have differed by study setting and have not been described in a UK primary care population. To describe rates of FEV1 and FVC decline in COPD and investigate chara...

The Role of the Pharmacist in Optimizing Outcomes With Roflumilast, a PDE4 Inhibitor fo...
https://doi.org/10.1177/0897190020969286
Journal of Pharmacy Practice; Williams D

Dec 3rd, 2020 - The pharmacology of roflumilast, recent dosing revisions, and the integral roles of pharmacists in effective chronic obstructive pulmonary disease (COPD) management are reviewed here. COPD is characterized by progressive airflow limitation and int...

Comparison of high-flow oxygenation with noninvasive ventilation in COPD exacerbation: ...
https://doi.org/10.1111/crj.13315
The Clinical Respiratory Journal; Rezaee A, Fakharian A et. al.

Dec 3rd, 2020 - To compare the therapeutic effects of high-flow-oxygen-Therapy (HFT) and noninvasive-ventilation (NIV) for stabilizing chronic obstructive pulmonary disease during exacerbation. In this randomized clinical trial at Masih-Daneshvari hospital, betwe...

Epicardial Adipose Tissue is Associated with Increased Systolic Pulmonary Artery Pressu...
https://doi.org/10.1111/crj.13316
The Clinical Respiratory Journal; Kalaycıoğlu E, Çetin M et. al.

Dec 3rd, 2020 - Pulmonary hypertension (PHT) is one of the essential predictors of mortality in chronic obstructive pulmonary disease (COPD). It is thought that PHT is due to vasoconstriction secondary to hypoxia caused by airway obstruction in COPD patients; how...

see more →

Guidelines  93 results

Office Spirometry: Indications and Interpretation
https://www.aafp.org/afp/2020/0315/p362.html
American Family Physician; Langan RC,et al

Mar 14th, 2020 - Approximately 1% to 4% of all visits to primary care offices are for dyspnea.1 The proper use of pulmonary function tests can help differentiate many of the causes of dyspnea, monitor the progression of chronic pulmonary disease, and assess respon...

Chronic Obstructive Pulmonary Disease: A 2019 Evidence Analysis Center Evidence-Based P...
https://doi.org/10.1016/j.jand.2019.12.001
Journal of the Academy of Nutrition and Dietetics; Hanson C, Bowser EK et. al.

Feb 16th, 2020 - Chronic obstructive pulmonary disease (COPD) is a progressive lung disorder in which patients are at high risk for both pulmonary and systemic complications of their disease. Medical nutrition therapy by a registered dietitian nutritionist can be ...

Metoprolol for the Prevention of Acute Exacerbations of COPD
https://www.nejm.org/doi/full/10.1056/NEJMoa1908142
The New England Journal of Medicine; Dransfield,M.,et al

Oct 19th, 2019 - Observational studies suggest that beta-blockers may reduce the risk of exacerbations and death in patients with moderate or severe chronic obstructive pulmonary disease (COPD), but these findings have not been confirmed in randomized trials.

Association Between Muscular Strength and Mortality in Clinical Populations: A Systematic Review and Meta-Analysis
https://www.jamda.com/article/S1525-8610(19)30441-4/fulltext
Journal of the American Medical Directors Association; Jochem C,et al

Sep 30th, 2019 - To assess the relationship between muscular strength measures and mortality in outpatient populations with chronic diseases such as cancer, chronic obstructive pulmonary disease, renal disease, and metabolic and vascular diseases, and in criticall...

Head‐to‐head oral prophylactic antibiotic therapy for chronic obstructive pulmonary disease
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013024.pub2/full
The Cochrane Database of Systematic Reviews; Threapleton,C.,et al

May 23rd, 2019 - Chronic obstructive pulmonary disease (COPD; including chronic bronchitis and emphysema) is a chronic respiratory condition characterised by shortness of breath, cough and recurrent exacerbations. Long‐term antibiotic use may reduce both bacterial...

see more →

Drugs  195 results see all →

Clinicaltrials.gov  37,785 results

Use of antidiabetic medications and risk of chronic obstructive pulmonary disease exace...
https://doi.org/10.1186/s12931-020-01547-1
Respiratory Research; Wang MT, Lai JH et. al.

Dec 3rd, 2020 - Exacerbation of chronic obstructive pulmonary disease (COPD) severely impacts the quality of life and causes high mortality and morbidity. COPD is involved with systemic and pulmonary inflammation, which may be attenuated with antidiabetic agents ...

Characteristics Associated with Accelerated Lung Function Decline in a Primary Care Pop...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701160
International Journal of Chronic Obstructive Pulmonary Disease; Whittaker HR, Pimenta JM et. al.

Dec 3rd, 2020 - Estimates for lung function decline in chronic obstructive pulmonary disease (COPD) have differed by study setting and have not been described in a UK primary care population. To describe rates of FEV1 and FVC decline in COPD and investigate chara...

The Role of the Pharmacist in Optimizing Outcomes With Roflumilast, a PDE4 Inhibitor fo...
https://doi.org/10.1177/0897190020969286
Journal of Pharmacy Practice; Williams D

Dec 3rd, 2020 - The pharmacology of roflumilast, recent dosing revisions, and the integral roles of pharmacists in effective chronic obstructive pulmonary disease (COPD) management are reviewed here. COPD is characterized by progressive airflow limitation and int...

Comparison of high-flow oxygenation with noninvasive ventilation in COPD exacerbation: ...
https://doi.org/10.1111/crj.13315
The Clinical Respiratory Journal; Rezaee A, Fakharian A et. al.

Dec 3rd, 2020 - To compare the therapeutic effects of high-flow-oxygen-Therapy (HFT) and noninvasive-ventilation (NIV) for stabilizing chronic obstructive pulmonary disease during exacerbation. In this randomized clinical trial at Masih-Daneshvari hospital, betwe...

Epicardial Adipose Tissue is Associated with Increased Systolic Pulmonary Artery Pressu...
https://doi.org/10.1111/crj.13316
The Clinical Respiratory Journal; Kalaycıoğlu E, Çetin M et. al.

Dec 3rd, 2020 - Pulmonary hypertension (PHT) is one of the essential predictors of mortality in chronic obstructive pulmonary disease (COPD). It is thought that PHT is due to vasoconstriction secondary to hypoxia caused by airway obstruction in COPD patients; how...

see more →

News  2,041 results

Patients With Mental Illness a Priority for COVID Vaccine, Experts Say
https://www.staging.medscape.com/viewarticle/940785

Nov 10th, 2020 - With this week's announcement that Pfizer's vaccine candidate against SARS-CoV-2 was 90% effective in preventing COVID-19, the world is one step closer to an effective vaccine. Nevertheless, with a limited supply of initial doses, the question bec...

Digital Intervention Beneficial for Patients Hospitalised with COPD Exacerbation
https://www.staging.medscape.com/viewarticle/940257

Nov 2nd, 2020 - A digital healthcare app called MyCOPD could help individuals with chronic obstructive pulmonary disease (COPD) to recover faster after hospital admission and decrease re-exacerbation of symptoms, suggests a new study published in the  NPJ Digital...

Digital Intervention Beneficial for Patients Hospitalised with COPD Exacerbation
https://www.medscape.com/viewarticle/940257

Nov 2nd, 2020 - A digital healthcare app called MyCOPD could help individuals with chronic obstructive pulmonary disease (COPD) to recover faster after hospital admission and decrease re-exacerbation of symptoms, suggests a new study published in the  NPJ Digital...

Oral Cannabinoid Drugs May Worsen COPD Outcomes
https://www.staging.medscape.com/viewarticle/939829

Oct 27th, 2020 - NEW YORK (Reuters Health) - Using prescription oral cannabinoid drugs is associated with increased rates of adverse outcomes in older patients with chronic obstructive pulmonary disease (COPD), a new study shows. COPD patients increasingly use pre...

Oral Cannabinoid Drugs May Worsen COPD Outcomes
https://www.medscape.com/viewarticle/939829

Oct 27th, 2020 - NEW YORK (Reuters Health) - Using prescription oral cannabinoid drugs is associated with increased rates of adverse outcomes in older patients with chronic obstructive pulmonary disease (COPD), a new study shows. COPD patients increasingly use pre...

see more →

Patient Education  27 results see all →